Darug, Julius G.

HRN: 26-00-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2024
CEFUROXIME 750MG (VIAL)
10/07/2024
10/14/2024
IV
750mg
Q8H
Lacerated Wound Sec To MVA
Rejected 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines